An abstract from the American Heart Association's Scientific Sessions 2026 reveals the continuous expansion of the GLP-1 medication class.
News|Expert Interviews|September 8, 2020
REDUCE-IT Trial Data Updates: Key Takeaways
A discussion on recent data updates from the REDUCE-IT trial, and their practical implications for physicians managing cardiovascular risk.
Advertisement
A discussion on recent data updates from the REDUCE-IT trial, and their practical implications for physicians managing cardiovascular risk.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Drug Topics
1
PBMs Must Now Disclose Fees to Employer Plans Under Final DOL Rule
2
COVID-19 Vaccine Lowers Venous Thromboembolism, Mortality Risk
3
PBM Audit Practices Under Scrutiny: What the House Inquiry Means for Independent Pharmacies
4
AI Prescribing Pilot Places Pharmacists as Final Link in Care
5